The safety of influenza vaccine in clinically cured leprosy patients in China-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The safety of influenza vaccine in clinically cured leprosy patients in China

Published:2017-12-14 Issue:3 Volume:14 Page:671-677
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Zheng Yi¹,Chen Li²,Zou Jie¹,Zhu Zheng-Gang³,Zhu Li¹,Wan Jing¹,Hu Quan¹

Affiliation:

1. Department of Leprosy, Wuhan Institute of Dermatology and Venereology, Wuhan, China

2. Department of Immunization, Jianghan Center for Disease Prevention and Control, Wuhan, China

3. Department of Immunization, Wuhan Center for Disease Prevention and Control, Wuhan, China

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2017.1390638

Reference23 articles.

2. Age- and Sex-related Risk Factors for Influenza-associated Mortality in the United States Between 1997–2007

3. T-Cell Regulation in Lepromatous Leprosy

4. The innate immune response in leprosy

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of misdiagnosed or delayed-diagnosed Leprosy bacillus infection from 1990 to 2020 with a prophet time series prediction in Hubei Province, China;Medicine;2023-08-11

2. The landscape of COVID-19 vaccination among healthcare workers at the first round of COVID-19 vaccination in China: willingness, acceptance and self-reported adverse effects;Human Vaccines & Immunotherapeutics;2021-10-07

3. Identification of sensitive indicators in immune response for leprosy affected patients;Medicine;2021-08-06

4. The landscape of COVID-19 vaccination among healthcare workers at the first round of COVID-19 vaccination in China: willingness, acceptance and self-reported adverse effects;2021-05-17

5. Is there a difference in the immune response, efficacy, effectiveness and safety of seasonal influenza vaccine in males and females? – A systematic review;Vaccine;2020-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3